1. Home
  2. KODK vs COLL Comparison

KODK vs COLL Comparison

Compare KODK & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

HOLD

Current Price

$9.86

Market Cap

1.1B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$34.12

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
COLL
Founded
1880
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
KODK
COLL
Price
$9.86
$34.12
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$51.40
AVG Volume (30 Days)
1.2M
400.7K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
$4,114,000,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$85.80
Revenue Growth
N/A
23.62
52 Week Low
$4.94
$28.74
52 Week High
$14.87
$50.79

Technical Indicators

Market Signals
Indicator
KODK
COLL
Relative Strength Index (RSI) 38.49 46.39
Support Level $6.04 $31.56
Resistance Level $9.96 $36.22
Average True Range (ATR) 0.70 1.67
MACD -0.35 -0.13
Stochastic Oscillator 11.78 11.85

Price Performance

Historical Comparison
KODK
COLL

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: